Lupus Research Alliance Advocates Win Big with 2019 Federal Funding
NEW YORK, NY. Sept. 28 – Congratulations go out to the Lupus Research Alliance advocates!
The 2019 spending bill was...
Search Results
You searched for: Research Portfolio
Results found: 856
Advocacy: The Critical First Step
Advocacy can mean different things to different people. Some seek to make changes in policy and funding at state...
LRA Announces Partners on the First Anniversary of the Lupus Landmark Study
The Lupus Research Alliance (LRA) and its clinical research affiliate Lupus Therapeutics (LT) are pleased to announce the group...
Lupus Accelerating Breakthroughs Consortium Announces Expanded Partnership with U.S. FDA at First Anniversary Meeting
The Lupus Research Alliance (LRA), founder and administrator of the Lupus Accelerating Breakthroughs Consortium (Lupus ABC), announced today at...
Lupus ABC First Anniversary Meeting Celebrated Remarkable Year of Accomplishments
Progress Shared and Future Course Charted
The Lupus Research Alliance (LRA) is pleased to report that the Lupus Accelerating Breakthroughs...
Raising Thousands for Lupus Research; Running the NYC Marathon for Life Without Lupus
November 4, 2019
Big thanks go to our Team Life Without Lupus, who put their heart and soul into running...
Stelara® Effective Over One Year and Reduces Severe Flares
Results of two analyses from a Phase 2 study of Stelara® (ustekinumab) in lupus showed the drug’s effectiveness over...
LRA-Funded Study Finds Lazy Enzyme that Triggers Autoimmunity
April 14, 2021
Dr. Boris Reizis and his team, working with a group of clinical rheumatologists led by Dr. Jill...
FDA Accepts Application for Gazyva® as Potential Lupus Nephritis Treatment
Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, is eager to share exciting news. The U.S....
Lupus Research Alliance Congratulates Dr. Betty Diamond for Well-Deserved Recognition by AAI
May 20, 2019
The LRA applauds Betty Diamond, MD for being named a Distinguished Fellow by the American Association of...
Lupus Research Alliance Pleased to Share Positive News about Potential Drug for Lupus Nephritis
NEW YORK, NY. June 11, 2019. The Lupus Research Alliance is pleased to share positive topline results from a...
Lupus Research Alliance Response to Positive Trial Testing Obinutuzumab (Gazyva®) for Lupus Nephritis
NEW YORK, Nov. 10, 2019 /PRNewswire/ -- The Lupus Research Alliance (LRA) is pleased to acknowledge positive results presented by...